Back to Results
First PageMeta Content
Bevacizumab / Ruxolitinib / Food and Drug Administration / Pharmacology / Pharmaceutical sciences / Medicine


Microsoft PowerPoint - 1-Widemann Welcome and FDA update.ppt
Add to Reading List

Document Date: 2012-04-08 15:24:08

Open Document

File Size: 20,25 KB

Share Result on Facebook

Event

Judicial Event / /

MedicalCondition

Tumor / Pain / Pulmonary / high risk myelofibrosis / tumors / disease / myelofibrosis / muscle pain / itching / /

Organization

FDA / office of Oncology Drug Products / /

Person

Scott Plotkin / Gregory Reaman / Brigitte Widemann / Oliver Hanemann / Rick Pazdur / Eva Dombi / /

Position

Chair / Director / Associate Director / Associate Director / former Chair / /

ProvinceOrState

Newfoundland / /

SocialTag